“Scientists know the gut microbiome plays an important role in cardiovascular disease risk, and new research suggests sexual dimorphism here too.”
We know that males and females are different. Scientists call it “sexual dimorphism,” where sexes within a species differ significantly—from their behaviour to the way their organs work.
This is true of the gut too. Your gut microbiome is the DNA belonging to trillions of bacteria in your bowel. Scientists know the gut microbiome plays an important role in cardiovascular disease (CVD) risk, and new research from the journal Biology of Sex Differences/ITC suggests sexual dimorphism here too.
Let’s look at sex differences in CVD by considering the gut microbiome and how it influences the three primary CVD risk factors: sugar and fat metabolism, blood pressure, and body weight.
Type 2 diabetes is a major CVD risk factor where the body is less sensitive (i.e. resistant) to insulin—a hormone that regulates blood sugar levels. So, how could diabetes risk differ in women compared to men?
The gut microbiome influences CVD risk by contributing to insulin resistance. This can happen in two ways: by bacteria interfering with signalling pathways, or by making branched-chain amino acids (BCAA’s) in the gut. Both promote inflammation.
Insulin signalling pathways are diminished by having too many Bacteroidetes and Firmicutes and not enough Proteobacteria bacteria. This sexual dimorphism may be partially explained by differences in sex hormone levels (i.e. more testosterone in men, and more estrogen and progesterone in women).
Female sex hormones can also protect against insulin resistance by speeding up the breakdown of BCAA’s in blood. And, females have less of the BCAA-producing species, Prevotella copri and Bacteroides vulgatus.
The main job of gut bacteria is to digest dietary fibre to make short-chain fatty acids (SCFA’s). SCFA’s may affect CVD risk by interacting with receptors in liver, heart, and muscle tissue to lower blood fat levels. According to an article published in Biology of Sex Differences, the SCFA’s in female mice influence these receptors much more strongly than in males. This suggests that women have a lower CVD risk than men because of their gut microbiome.
Second, women have more of the gut bacteria species that transform bile acids to alter blood fat levels favourably for CVD. These include: Clostridum, Eubacterium/, Ruminococcus, Coprococcus, Dorea, Lachnospira, Roseburia, and Butyrivibrio.
Also, certain gut bacteria influence the breakdown of sex hormones that are made from fats, affecting blood fat levels. Therefore, women, who tend to have more Firmicutes bacteria, may have a lower CVD risk than men.
The production of SCFA is not only associated with CVD risk relative to fat metabolism—it also influences blood pressure.
The SCFA propionate has been shown to reduce inflammation by affecting particular immune cells. Less inflammation means lower blood pressure and, thus, lower chances of developing CVD. So, if women consume more dietary fibre than men—totally within their control—they are likely to make more propionate and this may lower their overall CVD risk.
In contrast, the gut microbiome in male rats appears to raise blood pressure in arteries. This is because it aggravates the immune system. In other words, the gut bacteria in males favour inflammation, and this raises blood pressure and overall CVD risk.
But, bad news for women, too—Lactobacilli make compounds that are known to narrow blood vessels, raising blood pressure. Women typically have more Lactobacilli in their gut, predisposing them to CVD.
How else does the gut microbiome contribute to sexual dimorphism in CVD risk? Yes—body weight plays a role too.
Recent studies have found that obese women have more Firmicutes bacteria in their gut. In these women, Firmicutes extract more calories from food than other bacteria strains, further encouraging weight gain.
How do bacteria extract more calories exactly? Well, Firmicutes are better at making certain enzymes in obese women—ones that break down sugars that normally can’t be digested. This increases fat storage and promotes inflammation, which can contribute to weight gain and a higher CVD risk.
What’s more, certain SCFA’s increase the amount of fats that are stored in the body by activating specific enzymes in the liver. Women may make more of these liver enzymes than men, meaning that they store more fat and have a higher risk of obesity, and CVD.
Differences in the gut microbiome between males and females cause sexual dimorphism in CVD. The female gut microbiome is more likely to:
- make less BCAA’s and break them down quicker,
- make SCFA’s that are better at lowering blood fat levels,
- transform bile acids and make sex hormones in ways that improve blood fat levels, and
- encourage weight gain in women who are already obese.
Finally, although women are more likely to have higher blood pressure because of their gut bacteria composition, they can eat more dietary fibre to try and offset this increased CVD risk.
More Insights: Check this article out the push for new pain treatments for the terminally ill in Canada.
Author: Sophie Ash is a freelance medical writer and copywriter based in Toronto. She creates educational content in healthcare and pharmaceutical industries, across all therapeutic areas.